EP3056187

ALTERGON S.A.
Application Number
EP16154717A
Filing Date
Nov 13, 2012
Status
Patent Maintained As Amended
Jul 28, 2023
Grant Date
Aug 30, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3056187B2 was granted on Aug 30, 2023 by Altergon S.A. The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.May 17, 2019 N.A.

The table below shows the patents of Altergon S.A. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2034956Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic CystitisJun 28, 20231
EP3528847High-Stability Packaged Solutions Of T4 Thyroid HormoneJul 22, 20201

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.